Could A Weight-Loss Drug Hold Clues To Living Longer?

Scientists have been asking a big question about GLP-1 medicines: could the drugs behind today's weight-loss boom tell us something about aging itself? A new animal study offers an intriguing early answer — in mice.

The research, published Sept. 2, 2026 in the journal Nature and supported by the National Institutes of Health, comes from a team at the University of California, Berkeley led by Danica Chen. The researchers gave semaglutide, the active ingredient in several GLP-1 drugs, to healthy female mice that were already 20 months old — roughly late middle age for a lab mouse.

After three months of daily treatment, the older mice performed better on tests of muscle function and cognition, including memory and exploration, and showed fewer molecular signs of aging. Mice kept on the drug for the rest of their lives also lived longer: their median lifespan was 834 days, compared with 742 days for untreated mice — a gap of nearly 100 days.

Because semaglutide reduced the animals' food intake by about 24%, the team also compared it directly with a group of mice on a matched 24% calorie-restricted diet, a long-studied way of slowing aging in animals. The drug reproduced many of calorie restriction's benefits, and in some measures — exploratory behavior, spatial memory and blood sugar control — it did better. The authors say that suggests some effects may not be explained by eating less alone.

What it doesn't show

This is a mouse study, and only female mice were tested. It does not show that semaglutide slows aging or extends life in humans, and no one should take a GLP-1 medicine hoping to live longer. These are prescription drugs with real side effects, and decisions about them belong with a doctor.

What the work does provide is a sharper map for scientists: evidence that switching on the GLP-1 pathway late in life can change how aging unfolds in an animal, and a set of biological clues worth testing carefully in future research.

Would you want to see this kind of study tested in people, or is healthy aging something you'd rather tackle the old-fashioned way?